Frontlight ResearchEarly access
Metastatic breast cancer trials in United States
222 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleHippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer
- Where
- New York, San Francisco, Seattle
- Age
- 18 years and over
- People
- 22
- Run by
- University of Washington
See details and how to joinNCT06518057 - Phase 1Taking peopleFIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
- Where
- Atlanta, Boston, La Jolla, Los Angeles, Port Jefferson Station, Port Saint Lucie, St Louis, Tampa
- Age
- 18 years and over
- People
- 64
- Run by
- Regor Pharmaceuticals Inc.
See details and how to joinNCT05304962 - Phase 2Taking peopleSequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
- Where
- Atlanta, Fairway, Miami
- Age
- 18 years and over
- People
- 75
- Run by
- Reshma L. Mahtani, D.O.
See details and how to joinNCT06263543 - Phase 2Taking peopleAdaptive Therapy With Capecitabine for Treatment of Metastatic ER Positive, HER2 Negative Breast Cancer
- Where
- Scottsdale
- Age
- 18 years and over
- People
- 35
- Run by
- Mayo Clinic
See details and how to joinNCT06525766 - Phase 1/2Taking peopleORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
- Where
- Boston, Cleveland, Columbus, Fairfax, Fort Worth, Houston, Los Angeles, Nashville, New Haven, New York, Orlando, San Antonio, Sarasota, Seattle, Tampa
- Age
- 18 years and over
- People
- 380
- Run by
- Avenzo Therapeutics, Inc.
See details and how to joinNCT06998407 - Phase 2Taking peopleThe SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
- Where
- Boston
- Age
- 18 years and over
- People
- 72
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06439693 - Phase 2Taking peopleA Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 20
- Run by
- University of Washington
See details and how to joinNCT07078604 - No phaseTaking peopleA Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
- Where
- New York
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07225309 - Phase 1Taking peopleA Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
- Where
- Rochester
- Age
- 18 years and over
- People
- 54
- Run by
- Mayo Clinic
See details and how to joinNCT04521764 - Phase 2Taking peopleRash & Diarrhea Prophylaxis With Capivasertib
- Where
- New Haven
- Age
- 18 years and over
- People
- 108
- Run by
- Maryam Lustberg
See details and how to joinNCT07426822 - No phaseTaking peopleAdherence Intervention in Patients With Metastatic Breast Cancer
- Where
- New York
- Age
- 18 years to 99 years
- People
- 35
- Run by
- Columbia University
See details and how to joinNCT06121453 - Phase 2Not yet taking people in United StatesNeu Direction: Testing the Efficacy of Adding HER Inhibition to Standard of Care in Metastatic MLH1-low Endocrine-resistant ER+/HER2- Breast Cancer
- Where
- La Jolla
- Age
- 18 years and over
- People
- 150
- Run by
- University of California, San Diego
See details and how to joinNCT07729046 - Phase 1/2Taking peopleGemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer
- Where
- Columbus
- Age
- 18 years and over
- People
- 42
- Run by
- Margaret Gatti-Mays
See details and how to joinNCT06026657 - Phase 1Taking peoplePersonalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 28
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT05098210 - Phase 1/2Taking peopleAsciminib in HER2+ Breast Cancer Brain Metastases
- Where
- Durham
- Age
- 18 years and over
- People
- 42
- Run by
- Duke University
See details and how to joinNCT07136428 - Early phase 1Taking peopleFES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer
- Where
- Madison
- Age
- 19 years and over
- People
- 12
- Run by
- University of Wisconsin, Madison
See details and how to joinNCT04174352 - Phase 2Taking peopleDendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- Where
- Buffalo, Charlottesville, Tampa
- Age
- 18 years and over
- People
- 23
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT04348747 - Phase 1Taking peoplePhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
- Where
- Houston
- Age
- 18 years and over
- People
- 43
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05092373 - No phaseTaking peopleFast-Her: Fasting Effects on Breast Cancer Treatment
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 15
- Run by
- University of Minnesota
See details and how to joinNCT07624617 - No phaseTaking peopleQuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
- Where
- Baltimore, Chapel Hill, Chicago, Crown Point, Derby, Fairfield, Glastonbury, Greenwich, Guilford, Hartford, Houston, League City, New Haven, New Lenox, Orland Park, Philadelphia, Pittsburgh, Plainsboro, San Francisco, Seattle, Stamford, Sugar Land, The Bronx, Torrington, Trumbull, Washington D.C., Waterbury, Waterford, Westerly, Woodland
- Age
- 18 years and over
- People
- 200
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT06551116 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Atlanta, Aurora, Boston, Cleveland, Columbus, Dallas, Detroit, Fairfax, Germantown, Grand Rapids, Houston, Iowa City, Kansas City, Lake Mary, Los Angeles, Nashville, New Haven, New Orleans, New York, Portland, San Antonio, San Francisco, St Louis, Tampa, West Valley City
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - No phaseTaking peopleTreatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
- Where
- St Louis
- Age
- 18 years and over
- People
- 55
- Run by
- Washington University School of Medicine
See details and how to joinNCT04968964 - Phase 1/2Taking peopleSapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
- Where
- Austin, Lone Tree, Los Angeles, Nashville, San Antonio, Springfield
- Age
- 18 years and over
- People
- 32
- Run by
- Faeth Therapeutics
See details and how to joinNCT07558733 - Phase 4Taking peopleAn Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis
- Where
- Duarte
- Age
- 18 years and over
- People
- 10
- Run by
- City of Hope Medical Center
See details and how to joinNCT05376878 - No phaseTaking peopleCorrelation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 10,000
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01000883